These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15793151)

  • 1. Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study.
    Cantón E; Pemán J; Gobernado M; Alvarez E; Baquero F; Cisterna R; Gil J; Martín-Mazuelos E; Rubio C; Sánchez-Sousa A; Serrano C
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1604-7. PubMed ID: 15793151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.
    Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Holliday N; Killian SB
    J Clin Microbiol; 2004 Feb; 42(2):718-21. PubMed ID: 14766842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry susceptibility testing for the antifungal caspofungin.
    Mitchell M; Hudspeth M; Wright A
    J Clin Microbiol; 2005 Jun; 43(6):2586-9. PubMed ID: 15956368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2006 Mar; 44(3):760-3. PubMed ID: 16517851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micafungin activity against Candida bloodstream isolates: effect of growth medium and susceptibility testing method.
    Pai MP; Jones AL; Mullen CK
    Diagn Microbiol Infect Dis; 2007 May; 58(1):129-32. PubMed ID: 17240112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents.
    Alexander BD; Byrne TC; Smith KL; Hanson KE; Anstrom KJ; Perfect JR; Reller LB
    J Clin Microbiol; 2007 Mar; 45(3):698-706. PubMed ID: 17202279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin.
    Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskov A; Ramani R
    J Clin Microbiol; 2008 Jul; 46(7):2155-9. PubMed ID: 18463213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspofungin susceptibility testing of Candida inconspicua: correlation of different methods with the minimal fungicidal concentration.
    Majoros L; Kardos G; Szabó B; Sipiczki M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3486-8. PubMed ID: 16048965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
    Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome.
    Kartsonis N; Killar J; Mixson L; Hoe CM; Sable C; Bartizal K; Motyl M
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3616-23. PubMed ID: 16127030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species.
    Morace G; Amato G; Bistoni F; Fadda G; Marone P; Montagna MT; Oliveri S; Polonelli L; Rigoli R; Mancuso I; La Face S; Masucci L; Romano L; Napoli C; Tatò D; Buscema MG; Belli CM; Piccirillo MM; Conti S; Covan S; Fanti F; Cavanna C; D'Alò F; Pitzurra L
    J Clin Microbiol; 2002 Aug; 40(8):2953-8. PubMed ID: 12149358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.
    Pfaller MA; Espinel-Ingroff A; Jones RN
    J Clin Microbiol; 2004 Oct; 42(10):4577-80. PubMed ID: 15472311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.
    Hakki M; Staab JF; Marr KA
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2522-4. PubMed ID: 16801435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole.
    Espinel-Ingroff A; Canton E; Gibbs D; Wang A
    J Clin Microbiol; 2007 Mar; 45(3):858-64. PubMed ID: 17215342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method.
    Chryssanthou E
    J Clin Microbiol; 2001 Nov; 39(11):4181-3. PubMed ID: 11682555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Rodriguez-Tudela JL
    Clin Microbiol Infect; 2005 Jun; 11(6):486-92. PubMed ID: 15882199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of disc diffusion and microdilution methods in susceptibility testing of micafungin against Candida species.
    Ramírez M; Serrano MC; Castro C; López E; Almeida C; Fernández A; Romero A; Martín-Mazuelos E
    J Antimicrob Chemother; 2006 Oct; 58(4):861-3. PubMed ID: 16916868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered susceptibility of Candida glabrata bloodstream isolates to triazoles at clinically relevant pH values: comparison of the NCCLS M27-A2, Sensititre YeastOne, and Etest methods.
    Pai MP; Jones AL
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4441-3. PubMed ID: 15504877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.